Report
Pfizer raises 2026 revenue and adjusted earnings forecasts after third-quarter beat
Sales of newly launched and acquired products rose 32% operationally, even as COVID revenues weighed on the quarter.
TLDR
Pfizer lifted its 2026 revenue forecast to $62 billion to $64 billion and adjusted earnings outlook to $2.95 to $3.05 a share after third-quarter revenue and adjusted earnings topped analyst estimates. Sales of newly launched and acquired products grew 32% operationally, but overall quarterly revenue was relatively flat from a year earlier as COVID revenues declined. Cecile Guegan stepped in as CFO in November.
Combined views
32.6K
10 Sources, first seen ago
